Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease

Medicine & Life Sciences

• Peripheral Arterial Disease 100%
• Risk Reduction Behavior 92%
• Surgeons 64%
• Pharmacology 60%
• Blood Vessels 53%
• Drug Therapy 11%
• Self-Assessment 11%
• Angiotensin-Converting Enzyme Inhibitors 9%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 9%
• Canada 9%
• LDL Cholesterol 9%
• Psychology Recognition 8%
• Blood Glucose 8%
• Therapeutics 8%
• Patient Care 7%
• Cardiovascular Diseases 7%
• Lipids 6%
• Cross-Sectional Studies 6%
• Blood Pressure 6%
• Morbidity 5%
• Mortality 5%